Clinical trial
A Prospective, Controlled, Randomized, Multi-Center, Exploratory Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
NCT00544310 is registered in ClinicalTrials.gov with OMRIX Biopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Controlled, Randomized, Multi-Center, Exploratory Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
- Lead sponsor
- OMRIX Biopharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 31, 2008
- Completion date
- October 31, 2008
- Enrollment
- 25
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
bilateral ovarian disease